About Canopus Biopharma, Inc.
Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Salt Lake City, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CBIA is 0.0003 USD — it has decreased by 16.67% in the past 24 hours. Watch Canopus Biopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Canopus Biopharma, Inc. stocks are traded under the ticker CBIA.
CBIA stock has fallen by 37.50% compared to the previous week, the month change is a 25.00% rise, over the last year Canopus Biopharma, Inc. has showed a 99.51% decrease.
CBIA reached its all-time high on May 15, 1996 with the price of 9.3750 USD, and its all-time low was 0.0001 USD and was reached on Oct 27, 2023. View more price dynamics on CBIA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CBIA stock is 50.00% volatile and has beta coefficient of 9.90. Track Canopus Biopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Canopus Biopharma, Inc. there?
Yes, you can track Canopus Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
No, CBIA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CBIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Canopus Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Canopus Biopharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Canopus Biopharma, Inc. stock shows the sell signal. See more of Canopus Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.